[1]
Chakravarthi, S.C. et al. 2026. Next-Generation CAR-NK Immunotherapy for Myeloid Malignancies: From Target Discovery to Clinical Translation. Journal of Emerging Pharmaceutical and Medical Research (JEPMR). (Aug. 2026), 57–85.